Are you looking for the right contract development and manufacturing organization (CDMO) to develop and manufacture your high potency active pharmaceutical ingredients (HPAPIs)? Or have you been unsure about the CDMO you’re currently working with? In this free webinar, the featured speaker will explore the critical factors that should be considered when identifying and evaluating CDMOs for HPAPI for development and manufacturing. Other topics of discussion include the value of different types of containment technology, the significance of protocol during equipment changeovers and the advantages of certain cleaning strategies. Additionally, the speaker will review the important role of quality assurance in HPAPI manufacturing and delve into the questions you should ask a CDMO about their capabilities and corporate commitment to processing these complex APIs.View webinar
More from Curia
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate fro...